Clinical trial
The Dose Effect of Activated Clotting Time and Tranexamic Acid on Bleeding in Adult Cardiac Surgery
NCT06109155 is registered in ClinicalTrials.gov with Taichung Veterans General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Dose Effect of Activated Clotting Time and Tranexamic Acid on Bleeding in Adult Cardiac Surgery
- Lead sponsor
- Taichung Veterans General Hospital
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- February 8, 2024
- Completion date
- December 31, 2026
- Enrollment
- 150 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
activated clotting time, cardiopulmonary bypass, heparin, surgery, cardiac, tranxemic acid